“Overdiagnosis is increasingly recognized as a harm of breast cancer screening, particularly for older women,” the report said, noting that risk of cancer continues as women age but that the cancers detected often would not cause symptoms in a person’s lifetime.
Researchers at New Haven, Conn.-based Yale School of Medicine analyzed breast cancer diagnoses data from 54,635 women, dividing the data into three age groups within two “screened” and “unscreened” subsets. The age groups examined were: 70 to 74 years old, 75 to 84 years old and 85 and older. The study found that women in all three age groups were more likely to be diagnosed with additional breast cancers as they aged.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
